-- 高樂氏（Clorox，股票代號：CLX）週四晚間公佈了2025財年第三季調整後每股收益為1.64美元，高於去年同期的1.45美元。 FactSet調查的分析師先前預期為1.55美元。 截至3月31日的三個月內，公司營收為16.7億美元，與去年同期持平。 FactSet調查的分析師先前預期為16.7億美元。 該公司將2026財年調整後每股收益預期下調至5.45美元至5.65美元，低於先前預期的5.95美元至6.30美元區間的低端。分析師此前預期為5.87美元。 高樂氏股價在盤後交易下跌6.7%。
Related Articles
Asia
Shanghai International Airport's Q1 Profit Rises 11%
Shanghai International Airport's (SHA:600009) net profit attributable to shareholders in the first quarter rose 11% to 577.8 million yuan from the year-ago attributable profit of almost 519.0 million yuan, according to a Shanghai bourse filing on Thursday.Earnings per share climbed 10% year on year to 0.23 yuan from 0.21 yuan.Operating revenue inched 0.8% higher to 3.20 billion yuan from 3.17 billion yuan in the preceding year.
$SHA:600009
Asia
Shanghai International Airport's 2025 Profit Rises 10%, Revenue Climbs 8%
Shanghai International Airport's (SHA:600009) net profit attributable to shareholders in 2025 rose 9.5% to 2.12 billion yuan from 1.93 billion yuan a year earlier, according to a Shanghai bourse filing on Thursday.Earnings per share climbed 9% year on year to 0.85 yuan from 0.78 yuan.Operating revenue gained 7.9% to 13.35 billion yuan from 12.37 billion yuan in the previous year.
$SHA:600009
Asia
ResMed CFO to Retire
ResMed (ASX:RMD) said that Chief Financial Officer Brett Sandercock plans to retire, effective May 4, according to a Friday statement by the company.Aaron Bloomer will succeed Sandercock, who will remain an adviser to the chief executive through 2027, the company said.Bloomer was CFO of Exact Sciences, which was recently acquired by New York Stock Exchange-listed Abbott.
$ASX:RMD